MedTrace Logo

Congenital Cytomegalovirus: Prevalence in Buenos Aires City (cCMV Prevalence)

NCT05630898 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2022-11-30

No results posted yet for this study

Summary

The goal of this observational study is to recognise the prevalnce of congenital cytomegalovirus (cCMV) and to follow up positive babies until 12 months The main questions it aims to answer are: pevalence of cCMV, cCMV clinicals outcomes during the first year of life.

Participants will be screened with a salive swab for CMV DNA. Babies with positive results will be follow up for one year.

Conditions

  • Congenital Cytomegalovirus

Interventions

DIAGNOSTIC_TEST

CMV PCR

Saliva CMV PCR

Sponsors & Collaborators

  • Hospital de Niños R. Gutierrez de Buenos Aires

    lead OTHER

Principal Investigators

  • Daniela Satragno, MD · Hospital de Niños Ricardo Gutierrez

Eligibility

Min Age
1 Day
Max Age
21 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2024-09-30
Completion
2024-12-30

Countries

  • Argentina

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05630898 on ClinicalTrials.gov